TCIM
IMDZ

TIAA CREF Investment Management’s Immune Design Corp. IMDZ Stock Holding History

TIAA CREF Investment Management’s Portfolio IMDZ Stock Details IMDZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		$1.03M Hold
175,805
– – ﹤0.01% 2307
2018
Q4 		$229K Hold
175,805
– – ﹤0.01% 2849
2018
Q3 		$607K Sell
175,805
-3,865
-2% -$14.5K ﹤0.01% 2638
2018
Q2 		$817K Buy
179,670
+96,994
+117% +$386K ﹤0.01% 2575
2018
Q1 		$273K Buy
82,676
+19,484
+31% +$69K ﹤0.01% 2923
2017
Q4 		$246K Buy
63,192
+20,777
+49% +$113K ﹤0.01% 2981
2017
Q3 		$439K Sell
42,415
-22,804
-35% -$224K ﹤0.01% 2887
2017
Q2 		$636K Buy
65,219
+19,645
+43% +$138K ﹤0.01% 2750
2017
Q1 		$310K Buy
45,574
+7,236
+19% +$41.8K ﹤0.01% 2919
2016
Q4 		$211K Sell
38,338
-1,252
-3% -$8.84K ﹤0.01% 3035
2016
Q3 		$300 Sell
39,590
-3,933
-9% -$28.8K ﹤0.01% 2997
2016
Q2 		$355K Buy
43,523
+6,812
+19% +$85K ﹤0.01% 2992
2016
Q1 		$477K Hold
36,711
– – ﹤0.01% 2799
2015
Q4 		$737K Sell
36,711
-2,539
-6% -$43.7K ﹤0.01% 2754
2015
Q3 		$479K Buy
39,250
+6,354
+19% +$119K ﹤0.01% 2900
2015
Q2 		$679K Buy
32,896
+17,727
+117% +$419K ﹤0.01% 2867
2015
Q1 		$320K Hold
15,169
– – ﹤0.01% 3005
2014
Q4 		$467K Buy
15,169
+1,650
+12% +$45.9K ﹤0.01% 2984
2014
Q3 		$239K Buy
+13,519
New +$171K ﹤0.01% 3077

Other funds holding IMDZ

PS
Peter Svennilson $1.23B AUM 301.34% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TAL
TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $14.8B AUM 32.24% 1-Year Est. Return
SAM
Sandell Asset Management New York $179M AUM 65.55% 1-Year Est. Return
BCM
Beryl Capital Management Redondo Beach, California $110M AUM 317.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $55.1B AUM 24.23% 1-Year Est. Return

TIAA CREF Investment Management's IMDZ Position: Q1 2019 in Review

TIAA CREF Investment Management held its Immune Design Corp. (IMDZ) position steady in Q1 2019 at 175,805 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2307.

TIAA CREF Investment Management first reported a position in IMDZ in Q3 2014 and has held it in 19 quarters since. 68 funds tracked by Wall St. Rank hold IMDZ as of Q1 2019.

  • TIAA CREF Investment Management held 175,805 shares of Immune Design Corp. worth $1.03M as of Q1 2019.
  • TIAA CREF Investment Management left its Immune Design Corp. share count unchanged in Q1 2019.
  • Immune Design Corp. made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2307 holding.
  • TIAA CREF Investment Management first reported a position in Immune Design Corp. in Q3 2014 and has held it in 19 quarters since.
  • 68 funds tracked by Wall St. Rank held Immune Design Corp. as of Q1 2019.

Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.